Clinical Care
Providing exceptional treatment for patients close to home.
The UVM Cancer Center delivers comprehensive world-class cancer care across sites in Vermont and northern New York.
These sites include FitzPatrick Cancer Treatment Center at Champlain Valley Physicians Hospital; the National Life Cancer Treatment Center at Central Vermont Medical Center; the Reddy Cancer Treatment Center at Alice Hyde Medical Center; Elizabethtown Community Hospital; Porter Medical Center; and the UVM Medical Center—the UVM Health Network's academic medical center. Furthermore, the UVM Cancer Center operates broadly across the community in collaboration with organizations and clinical sites to facilitate specialized care, clinical research, cancer prevention, screening, and community education.
Patient visits in 2024
Percentage of people with cancer in Vermont and northern New York who receive care at the UVM Cancer Center.
Eric Bergeron of Colchester, Vermont, received life-saving CAR T-Cell therapy at the UVM Cancer Center.
One Year Later, Innovative New Cancer Treatment is Saving Lives
Launched in February 2023, the Cancer Center’s CAR T-Cell therapy program is the only one of its kind in Vermont and northern New York to provide the treatment, which trains a patient’s own T-cells to recognize and attack cancer cells. A year later, many in the first cohort of patients remain cancer-free. Eric Bergeron of Colchester, Vermont, is one of those patients.
Data has shown that if patients are cancer free for three months, around 80% of patients will go four years without relapsing and it could be longer as well. “I hope to be in the 80%," says Eric Bergeron.
Clinical Trial Tests Effectiveness of Online Strength Training in Slowing Muscle Wasting in Lung Cancer Patients
Resistance and strength training can greatly benefit patients suffering from sarcopenia -- the wasting of muscle tissue and function that can follow chemotherapy and chemoradiation. But what if you live in a rural area and are unable to attend in-person fitness classes? A study led by Hibba Rehman, M.D., a physician researcher at UVM’s Larner College of Medicine, investigates whether online fitness classes can be an effective option for preventing sarcopenia among Stage 3 and Stage 4 Lung Cancer Patients.
Chris Holmes, M.D., Ph.D., Medical Director for Cancer Clinical Programs at the UVM Health Network
Chris Holmes, M.D., Ph.D., Appointed Medical Director for Cancer Clinical Programs at UVM Health Network
In 2024, Chris Holmes, M.D., Ph.D., joined UVM Cancer Center and UVM Health Network as Medical Director for Cancer Clinical Programs. Dr. Holmes, a Professor of Medicine at the University of Vermont’s Larner College of Medicine, was formerly the Deputy Division Chief for Hematology/Oncology at the Cancer Center. In her new role, she works closely with providers and leaders across multiple departments and divisions to coordinate cancer care across the network and ensure the highest quality of cancer care for patients.
Kevin Vest, MBA joins UVMCC as Network Vice President, Cancer Clinical Programs
In 2024, we welcomed Kevin Vest, M.B.A., to the position of Network Vice President, Cancer Clinical Programs. Mr. Vest, a Fellow in the American College of Healthcare Executives, joined the UVM Cancer Center from Yale Cancer Center.
As Network Vice President, Mr. Vest oversees cancer-related clinical activities with a primary focus on adult oncology specialties including hematology/medical oncology, radiation oncology, surgical oncology, gynecologic oncology and neurooncology. He partners with UVM Cancer Center, UVM Health Network and Larner College of Medicine departmental leadership to implement plans to support a coordinated strategic vision and efficient operations across all network sites.
Kevin Vest, M.B.A., UVM Health Network Vice President, Cancer Clinical Programs